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Abstract To characterize the clinical manifestations of patients
with systemic sclerosis who develop a myocardial infarction (MI), a
retrospective review of the medical records of all patients who were
admitted to our institution between 1982 and 2002 and had the
dual diagnosis of systemic sclerosis and an acute MI was done.
From 1,009 systemic sclerosis hospital admissions, 11 (1.09%)
were for an acute MI. Three of these patients had normal
coronaries, and instead of wall motion abnormalities, left ventricular
hypertrophy was the predominant finding of an echocardiography.
The odds ratio of finding normal coronaries in systemic sclerosis vs
the general population who develops an acute MI is 33.89 (14.08–
81.39). Seven of our patients had an elevated creatinine level on
presentation. Acute MI is an uncommon manifestation in systemic
sclerosis patients. Normal coronaries are seen more commonly in
these patients as compared to the general population, while
vascular, gastrointestinal, and renal involvement is prevalent in
these patients.
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Introduction  
Endothelial cell dysfunction is one of the fundamental abnormalities 
in the pathogenesis of systemic sclerosis causing a progressive 
vasculopathy most commonly involving the microvasculature 
system. Less frequently, the vasculopathy of systemic sclerosis 
may affect larger vessels. The most common clinical manifestation 
of systemic sclerosis vasculopathy is Raynaud’s phenomenon, and 
involvement of the kidneys, lungs, and the heart has been 
extensively described. The vessels most commonly involved are 
small arterioles (500–50 µ in diameter) and capillaries. Only rarely 
has involvement of larger vessels been described [1, 2].  
Cardiac involvement in systemic sclerosis is not uncommon, 
occurring in approximately 20–25% of patients [3–5]. The most 
prevalent clinical manifestations are angina, conduction defects, 
myocardiopathies related to myocardial fibrosis, and arrhythmias. A 
coronary artery vasospastic phenomenon (“Raynaud’s 
phenomenon”) has also been described, and it has been 
suggested that this alteration may cause myocardial ischemia with 
angina symptoms as well as reperfusion injuries, leading to the 
development of myocardial fibrosis [6].  
 
The aim of this study was to characterize the clinical 
manifestations of patients with systemic sclerosis who were 
hospitalized at our institution for an acute myocardial infarction (MI) 
between the years 1982 and 2002 and to identify a subgroup of 
patients from this cohort who did not exhibit coronary vessel 
atherosclerosis by cardiac catheterization or postmortem studies. 
The clinical characteristics of this subgroup of patients were 
examined in detail and were compared to historical control cases of 
non-atherosclerotic MIs in the general population.  
 
The prevalence rate of MI with normal to near-normal coronary 
arteries in the general population varies between 1 and 12% 
depending on the definition of “normal coronary vessels” [7–10]. 
This pattern is more commonly seen in younger individuals. In 
patients below 30 years of age, it accounts for 16–35% of MIs [11]. 
The etiology of this syndrome is not clearly defined at this time, 
although endothelial dysfunction, coronary microembolism, coro-
nary vasospasm, an imbalance in oxygen supply and demand, and 
nonatherosclerotic coronary artery disease have been postulated 
as likely mechanisms.  
Patients and methods  
The inpatient medical record database of our institution, which is a 
tertiary, university-based referral center, with a scleroderma clinic 
that draws patients predominantly from the northeast part of the 
USA, was searched using the diagnostic codes for systemic 
sclerosis and acute MI. Cases were located among admissions 
between 1982 (when the computerized database was first 
established at our institution) and 2002. Twelve patients who 
carried the dual diagnosis of systemic sclerosis and acute MI were 
identified based on the diagnostic codes used, which included 
coding changes implemented through the years of ascertainment. 
The study was approved by the Institutional Review Board. A 
thorough evaluation of the medical records allowed us to confirm 
the diagnosis of systemic sclerosis in all except one of the patients 
identified. All patients had a clearly defined history of MI which was 
based on electrocardiographic changes and at least a twofold 
increase in myocardial creatine kinase activity on presentation. The 
demographic data of each patient being admitted to the hospital for 
a MI were collected. The presence and severity of systemic 
sclerosis visceral organ involvement were assessed employing a 
previously described systemic sclerosis severity scale [12]. In this 
scale, involvement of nine specific organs is rated from 0 (no 
documented involvement) to 4 (end-stage disease).  
Statistical analyses Quantitative data are presented as a mean with 
a standard deviation, while qualitative data are presented as a 
percentage of the total or as a ratio. The patients for whom clinical, 
radiologic, or pathologic reports were not adequate to delineate 
whether they had atherosclerotic cardiovascular disease were 
assumed to have atherosclerosis to obtain the most conservative 
estimate of nonatherosclerotic disease in the cohort studied. 
Employing historical controls from a similarly designed 
retrospective cohort study which examined MI admissions in the 
general population with angiographically normal coronary arteries, 
we calculated the odds ratio of having angiographically normal 
coronary arteries in systemic sclerosis patients who had a recent 
MI as compared to the general population, and a 95% confidence 
interval is given [4].  
Results  
From 1,009 systemic sclerosis hospital admissions to our institution 
between 1982 and 2002, 11 (1.09%) were for an acute MI. The 
average age of this group of patients was 64.4±7.9 years old. Six 
patients were women (54.5%), nine were white (81.8%), and two 
were African-American (18.2%). Seven patients had limited 
cutaneous systemic sclerosis (LcSSc) (63.6%), and four patients 
had diffuse cutaneous systemic sclerosis (DcSSc) (36.4%). 
Prevalent clinical symptoms related to systemic sclerosis were gas-
trointestinal (91%), peripheral vascular (81.8%) (seven out of nine 
with severe Raynaud’s phenomenon), and renal (36.4%). The 
extent of skin involvement based on total body surface clinically 
affected by the sclerotic process was 15.1±12.3% (Table 1). 
Modified Rodnan skin scores were not performed during the 
inpatient hospitalization. Seven out of nine patients had positive 
antinuclear anti-bodies. None of eight patients tested for 
anticardiolipin antibodies were positive, and only one of eight 
tested for lupus anticoagulant was positive. On presentation, 8 of 
11 patients had substernal chest pain, and 3 of 11 had orthopnea 
and dyspnea. Mean initial creatinine phosphokinase (CK) was 608 
± 366 IU/l and CK-MB, 57.6±47.7 IU/l (normal values for CK and 
CK-MB were 30–170 and 0–7 IU/l, respectively.) Mean creatinine 
level was 2.09 ± 0.69 mg/dl. Out of 11 patients, 4 had typical 
clinical and laboratory manifestation of scleroderma renal crisis on 
admission. Out of 11 patients, 2 had new-onset atrial fibrillation, 
and 4 out of 11 had electrocardiographic evidence of 
intraventricular conduction abnormalities. On chest X-ray 
evaluation 45.4% of patients had signs of congestive heart failure, 
27.2% had pleural effusions, and 27.2% had interstitial lung fibrosis 
changes. Initial blood pressure was 134 ± 17.8/77 ± 12.4 mm Hg. 
Five patients had clearly defined atherosclerotic changes by 
cardiac catheterization or examination of autopsy specimens 
(45.4%), whereas three (27.2%) patients had normal coronary 
arteries. In three cases the atherosclerotic status could not be 
clearly defined. Out of 11 patients, 9 developed non-Q wave MIs. 
All three of the nonatherosclerosis patients displayed this pattern. 
On two-dimensional (2-D) echocardiography upon admission to the 
hospital, the nonatherosclerotic cases showed no wall motion 
abnormalities but concentric left ventricular hypertrophy (LVH) as 
compared to the patients with atherosclerotic heart disease who 
had wall motion abnormalities but no LVH. Four patients died 
during these admissions, two from infections and two from 
cardiogenic shock. From three autopsies performed, two patients 
had moderate coronary atherosclerosis. The autopsy of the third 
patient did not show any atherosclerotic changes, but perivascular 
fibrosis of the coronary vessels and a diffuse lymphocytic infiltrate 
of the myocardium were observed (Figs. 1 and 2).  
 
Using as a historical control a previous retrospective study of 23 
patients who had normal coronary arteries on angiography out of a 
total 2,100 acute MI admissions [7], we calculated a significantly 
higher odds of having normal coronary arteries in patients with 
systemic sclerosis and an acute myocardial infarct as compared to 
a control population (OR 33.86, 95% CI 14.08–81.39).  
Discussion  
Acute MI is an uncommon complication of SSc. It has been 
suggested that some cases of MI in these patients may be caused 
by coronary vasospasm rather than by atherosclerotic coronary 
disease [6]. Indeed, thallium perfusion studies have provided 
strong evidence that perfusion defects are common in patients with 
systemic sclerosis and can occur both at rest and in response to 
cold pressor provocation [13–16]. Because there is no evidence of 
an increased risk for coronary atherosclerosis in this disease, it is 
most likely that endothelial dysfunction plays a central role in the 
involvement of the coronary vessels. The pathogenesis of coronary 
vessel alterations in systemic sclerosis has been hypothesized to 
result in a combination of both the typical microvascular disease 
often present in SSc and atherosclerotic disease. It has been 
suggested that perivascular cellular infiltrates with activated T cells 
are responsible for the production and secretion of cytokines such 
as transforming growth factor (TGF)-P, which injure the endothelial 
cells and cause an increased expression of major histocompatibility 
complex (MHC) class I and II antigens as well as of the adhesion 
ligand intracellular adhesion molecule-1. Chemoattraction of 
fibroblasts into the vessel wall most likely under the influence of 
locally secreted TGF-P and their subsequent transdifferentiation 
into myofibroblasts capable of increased production of collagens 
and other extracellular matrix proteins cause a reduction in the 
coronary lumen and vasomotor instability. These changes in the 
vessel wall lead to endothelial injury, with exposure of the 
subendothelium causing subsequent platelet aggregation and 
thrombus formation [1]. In autopsy studies extramural coronary 
vessels are often normal, while smaller intramural vessels show 
intimal proliferation and intravascular thrombosis [17–19].  
 
Cardiac wall motion abnormalities on 2-D echocardiography were 
surprisingly absent in all three patients who did not have 
atherosclerotic coronary artery disease, although concentric LVH 
was uniformly present. In contrast, in patients who had 
atherosclerotic disease, there were pronounced myocardial motion 
abnormalities without LVH. These observations suggest that 
coronary ischemia related to coronary vasospasm may be 
responsible for the occurrence of MI in patients with SSc.  
 
In our case series, 64% of SSc patients who developed MI had a 
creatinine level of more than 1.3 mg/dl, and four were in 
scleroderma renal crisis. While this may be in line with early 
investigators who suggested that cardiac involvement in SSc may 
be a manifestation of disease in other organs such as the kidneys 
and the lungs [20], and the heart is involved secondary to the 
associated systemic and pulmonary hypertension, it may also 
represent a similar pathogenic process which leads these patients 
to both have coronary and peripheral vascular involvement.  
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Table & Figures 
 
Table 1 Demographics of 11 SSc patients with acute myocardial infarction  
_____________________________________________________ 
Age (years)  64.4±7.9 
Sex (%)   
Female  54.50  
Race (%)   
White  81.80  
African-American  18.20  
Clinical subset of SSc (%)   
Limited  63.60  
Diffuse  36.40  
SSc symptoms (%)   
Gastrointestinal  91  
Raynaud’s phenomenon  81.80  
Renal involvement  64  
TBS skin involvement  15.1±12.3 
SSc Systemic sclerosis, TBS total body surface 
 
Fig. 1 Perivascular hyperplasia with fibrous deposition in a small 
coronary vessel without atheroma and with total lumen occlusion. 
 
Fig. 2 Diffuse lymphocytic infiltrates of the myocardium 
 
